R. Pimenta, J. Costa-Rosa, M. Cravo, M. Rafael, and C. Moura, “Cutaneous Adverse Events of Targeted Therapies and Immune-Checkpoint Inhibitors in Patients with Melanoma”, SPDV, vol. 79, no. 1, pp. 11-20, Apr. 2021.